The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1247
ISSUE1247
November 6, 2006
Decitabine (Dacogen) for Myelodysplastic Syndromes
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Decitabine (Dacogen) for Myelodysplastic Syndromes
November 6, 2006 (Issue: 1247)
Decitabine (Dacogen - MGI Pharma), a pyrimidine nucleoside analog of cytidine, was approved by the FDA as an orphan drug for treatment of myelodysplastic syndromes (MDS), a heterogeneous group of clonal hemopathies that decrease production of normal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.